The best care is collaborative. 🤝 Don’t miss your chance to join the premier community dedicated to elevating the patient experience. Secure your spot at #ASCOQLTY26 in Boston and save with early bird rates by August 26: https://bit.ly/4c3z6Cc

Among patients with advanced #BiliaryTractCancer, durvalumab plus gemcitabine and cisplatin provided sustained 4-year overall survival benefit and a comparable safety profile vs placebo plus chemotherapy ja.ma/4ygxazN

The draft guideline recommendations for "Integration of Patient-Reported Outcomes in the Routine Care of Adults Undergoing Systemic Treatment for Cancer" are now available. Help us refine these standards of care. Submit your feedback to us by July 22: https://bit.ly/4h3Xkzx

🚨 @ascocancer.bsky.social #ASCOQLTY26 provides an unparalleled opportunity to present data-driven science to help educate the oncology community & elevate care for all. It's the LAST DAY to share your work & contribute to the conversation on patient-centered outcomes. 👉 www.asco.org/quality

Propel your career forward by submitting your research on topics ranging from Cost, Value & Policy to Tech. Innovation in Quality Care to #ASCOQLTY26 in Boston. Let’s advance quality cancer care together. ☕ Grab your Dunks & submit an abstract by June 16 at 11:59 PM (ET): https://bit.ly/49NsXsK

Among patients with early age–onset #ColorectalCancer in Texas, treatment delays longer than six weeks were associated with reduced survival, and language barriers represented a major risk factor contributing to delayed initiation of definitive therapy. ja.ma/3S1igN7

Older adults with advanced cancer mainly prioritized quality of life, but their treatment preferences were not associated with differences in survival, hospitalization, or adverse effects. ja.ma/3RwiJH5

Heading home from #ASCO26 today! Put two dates for @ascocancer.bsky.social Quality Care Symposium on your calendar: 🚨Abstracts are due in 2 weeks 6/16/2026 📆 #ASCOQLTY26 is Friday-Saturday 10/16-17/2026 See you in Boston! www.asco.org/quality

Adding intraperitoneal paclitaxel to intravenous paclitaxel plus S-1 improved overall survival for #GastricCancer with peritoneal metastasis, with safety profiles comparable to intravenous-only therapy. ja.ma/3PA3fAX

Rural counties had stable or increased #LiverCancer (#HCC) incidence and mortality rates from 2001 to 2022, while urban counties experienced decreases, highlighting persistent rural-urban disparities. ja.ma/4nvw0ve

Cancer cachexia: A tumor-driven disorder of whole-body homeostasis

Cancer cachexia: A tumor-driven disorder of whole-body homeostasis

Cancer cachexia is a tumor-driven collapse of systemic homeostasis rather than a passive consequence of advanced disease. In this review, Zhang et al. define a tumor-centric framework in which tumor-derived signals rewire immune, metabolic, and neuroendocrine networks across organs, establishing self-sustaining catabolic feedback loops. This model provides a conceptual foundation for biomarker-guided and mechanism-based therapeutic strategies.

dlvr.it

Recommend a colleague by June 5, 2026, for the upcoming ASCO Election. Learn more and submit your recommendations: https://bit.ly/4cKmkYI

Elevate the quality, safety & efficiency of cancer care delivery—submit your research to #ASCOQLTY26. By presenting findings, you’re shaping a vibrant community of professionals dedicated to advancing patient care. Prepare your submission: https://bit.ly/4cF0WUW

Older adults with advanced #cancer mainly prioritized quality of life, but their treatment preferences were not associated with differences in survival, hospitalization, or adverse effects. ja.ma/4bf65m0

Dr @lpetrillz.bsky.social accepts the #EarlyCareer Investigator award here at @aahpm.bsky.social's #hapc26 for her innovative and revolutionary work in #pallonc and #survonc. Well deserved!! 👏 @realbowtiedoc.bsky.social @darcyburbage.bsky.social @ascocancer.bsky.social @crisbergerot.bsky.social

Outcomes of Older Adults With Advanced #Cancer Who Prefer Quality of Life vs Prolonging Survival: A Secondary Analysis of the GAP70+ Cluster Randomized Clinical Trial. jamanetwork.com/journals/jam... @jama.com @jamaoncology.com #GeriOnc #SuppOnc @mycarg.bsky.social

Analysis of US mortality data indicates breast cancer, lung cancer, and leukemia deaths decreased in people younger than 50, while #ColorectalCancer mortality rose to become the leading cancer death by 2023. ja.ma/4qN1RII

Among #Medicare Advantage beneficiaries aged 75 years or older with #cancer, a lay health worker–administered telephone assessment reduced acute care use, including 68% lower odds of hospitalization, compared with standard care. ja.ma/4plhA05

💬 Editorial: A randomized trial in community oncology clinics demonstrated that telephone-based lay health worker–administered PRO assessments for older adults with #cancer resulted in reductions in acute care utilization and lower mortality. ja.ma/4ax5ygt

Among over 7000 patients with #cancer, higher baseline fatigue before systemic therapy was linked to an increased risk of severe, life-threatening, and fatal adverse events. ja.ma/4qmZtrt

Great session! Thank you @ryannipp.bsky.social ! Mark your calendars for #ASCOQuality in Boston on 10/16-10/17/2026!

Dr Joseph McCollom DO@realbowtiedoc.bsky.social · 10mo ago

Happening now! @ryannipp.bsky.social leads us in @pallonccop.bsky.social for a summary for #ASCOQLTY25! Join now!! @tingtingzhang.bsky.social @fionnualacrowley.bsky.social @ericroeland.bsky.social @mazietsangmd.bsky.social @ascocancer.bsky.social @darcyburbage.bsky.social @rsedhom.bsky.social

Join us this Thursday to hear the highlights from #ASCOQLTY25 with #ASCOQLTY Chair Elect @ryannipp.bsky.social DM for the link or to be added to our mailing list. @realbowtiedoc.bsky.social @crisbergerot.bsky.social @ericroeland.bsky.social @fionnualacrowley.bsky.social #pallonc

💕 A big “thank you” to our #ASCOQLTY25 Featured Voices! Their expertise and insights are invaluable. We're so lucky to have them! @fumikochino.bsky.social @crisbergerot.bsky.social @ryannipp.bsky.social

Great to hear an expert discussion on #FinancialToxicity from Dr. Jeffrey Peppercorn at #ASCOQLTY25 this afternoon! meetings.asco.org/2025-asco-qu... @ascocancer.bsky.social #PallOnc #SuppOnc #CancerResearch

I am honored to give the #ASCOQLTY25 Simone Award to @drrobinyabroff.bsky.social today. Dr Yabroff has a profound impact as a researcher, policy advocate, & mentor. It's hard to find someone in health services research that hasn't been positively influenced by her intellect, wit, & warmth.🏆

Excellent first session this morning at #ASCO Quality Care Symposium: “Partners in Care: Building Bridges Through Shared Decisions.” meetings.asco.org/meetings/202... #ASCOQLTY25 #CancerCare #CancerResearch @ascocancer.bsky.social

The 2025 @ascocancer.bsky.social Quality Care Symposium #ASCOQLTY25 will feature >600 abstract presentations covering the latest implementation science and the entire spectrum of health services research. 📖 Review abstracts today! ✈️ Join us this weekend in Chicago meetings.asco.org/abstracts-pr...

🚨 #ASCOQLTY25 Registration Alert‼️ (before rates go up this Friday)! 🗣️ Engage in meaningful discussions 🤝 Build lasting relationships 🔋 Leave feeling energized & inspired ➡️ Join us in Chicago Oct 10-11, 2025 @ascocancer.bsky.social www.asco.org/quality/registration-hotels/registration-details

Chair-Elect @ryannipp.bsky.social, MPH, FASCO, attended @ascocancer.bsky.social Quality as a trainee, and the science, education, and community he found there has kept him coming back.   “For many of us, it is our favorite meeting of the year." #ascoQLTY25

Sharing Decision-Making, Providing Cancer Care During Catastrophes, and More: Sessions to Attend at the 2025 ASCO Quality Care Symposium

The 2025 ASCO Quality Care Symposium (QCS) will take place on October 10 and 11 and focus on the theme of “Driving Solutions, Implementing Change.” The Symposium includes sessions on shared decision-m...

dailynews.ascopubs.org

Truly honored to be a featured voice at #ASCOQLTY25 alongside such inspiring colleagues who are shaping the future of quality cancer care Join us in Chicago & online, Oct 10–11, for sessions on shared decision-making, advancing quality cancer care and much more @ascocancer.bsky.social

American Society of Clinical Oncology@ascocancer.bsky.social · 12mo ago

We’re excited to announce the ASCO Quality Care Symposium Featured Voices! Follow them before, during & after the event for expert insights & to be a part of the meeting experience. Join the conversation w/ the official hashtag #ASCOQLTY25. Registration is still open: brnw.ch/21wVoQS